1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Posters by Title

Showing 1,267 results.

MM - 893

Early IVIG Use and Infectious Complications After Bispecific Antibody Therapy in Multiple Myeloma

Vishw Patel

Poster Presenter: Vishw Patel

Thumbnail for Early Mortality After Allogeneic Hematopoietic Cell Transplantation According to Donor Type: A Single-Center Retrospective Cohort Study

CT - 191

Early Mortality After Allogeneic Hematopoietic Cell Transplantation According to Donor Type: A Single-Center Retrospective Cohort Study

Eugenia P?rez Lloveras

Poster Presenter: Eugenia P?rez Lloveras

CT - 1048

Early Mortality Following CAR-T Therapy in Hematologic Malignancies: A Population-Level Study

Nanditha Karra

Poster Presenter: Nanditha Karra

Thumbnail for Early Mortality in Acute Leukemias: Real-World Data From a Resource-Limited Public Referral Center in Baja California Sur, Mιxico, 2022-2026.

ALL - 896

Early Mortality in Acute Leukemias: Real-World Data From a Resource-Limited Public Referral Center in Baja California Sur, Mιxico, 2022-2026.

Emmanuel Avenda?o

Poster Presenter: Emmanuel Avenda?o

CLL - 1118

Early Outcomes of a Multistakeholder Treatment Access Program for Chronic Lymphocytic Leukemia in Armenia, Ethiopia, and Nepal

Lauren Herzog

Poster Presenter: Lauren Herzog

$Thumbnail for Early Real-World Outcomes of Revumenib Versus Venetoclax-Based Salvage Therapy in Relapsed or Refractory Acute Leukemia$

AML - 911

Early Real-World Outcomes of Revumenib Versus Venetoclax-Based Salvage Therapy in Relapsed or Refractory Acute Leukemia

Vishw Patel

Poster Presenter: Vishw Patel

Thumbnail for Early Real-World Utilisation, Resource Use, and In-Hospital Outcomes of BCMA-Directed Bispecific Antibodies in Multiple Myeloma: A National Inpatient Analysis, 2022-2023

MM - 225

Early Real-World Utilisation, Resource Use, and In-Hospital Outcomes of BCMA-Directed Bispecific Antibodies in Multiple Myeloma: A National Inpatient Analysis, 2022-2023

Aniqa Baloch

Poster Presenter: Aniqa Baloch

$Thumbnail for Early Resolution of Talquetamab Oral Side Effects in Relapsed/Refractory Multiple Myeloma (RRMM): Updated Waterless Empirical Taste Test (WETT) and Patient Reported Outcomes (PRO) Data From TALisman$

MM - 793

Early Resolution of Talquetamab Oral Side Effects in Relapsed/Refractory Multiple Myeloma (RRMM): Updated Waterless Empirical Taste Test (WETT) and Patient Reported Outcomes (PRO) Data From TALisman

Nolan Ngo

Poster Presenter: Nolan Ngo

Thumbnail for Early Transfusion Independence as a Real-World Prognostic Marker After Hypomethylating Agent-Venetoclax Therapy in Older Adults With Acute Myeloid Leukemia

AML - 1096

Early Transfusion Independence as a Real-World Prognostic Marker After Hypomethylating Agent-Venetoclax Therapy in Older Adults With Acute Myeloid Leukemia

Fathima Shehnaz Ayoobkhan

Poster Presenter: Fathima Shehnaz Ayoobkhan